These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24815991)
1. Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis. Suguro M; Yoshida N; Umino A; Kato H; Tagawa H; Nakagawa M; Fukuhara N; Karnan S; Takeuchi I; Hocking TD; Arita K; Karube K; Tsuzuki S; Nakamura S; Kinoshita T; Seto M Cancer Sci; 2014 Jul; 105(7):897-904. PubMed ID: 24815991 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS). Carreras J; Kikuti YY; Beà S; Miyaoka M; Hiraiwa S; Ikoma H; Nagao R; Tomita S; Martin-Garcia D; Salaverria I; Sato A; Ichiki A; Roncador G; Garcia JF; Ando K; Campo E; Nakamura N Histopathology; 2017 Mar; 70(4):595-621. PubMed ID: 27775850 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763 [TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944 [TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder]. Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151 [TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165 [TBL] [Abstract][Full Text] [Related]
7. Transformation of follicular lymphoma. Lossos IS; Gascoyne RD Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis]. Tagawa H Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of splenic tumours of lymphoid tissue. Chen DB; Shen DH; Yang SM; Fang XZ Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035 [TBL] [Abstract][Full Text] [Related]
10. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938 [TBL] [Abstract][Full Text] [Related]
11. Lymph node hyperplasia: clonal chromosomal and genomic rearrangements. Report of two new cases and literature review. Villa N; Redaelli S; Lissoni S; Saccheri F; Sala E; Crosti F; Dalprà L; Carrino V; Pioltelli P; Isimbaldi G Cancer Genet; 2014; 207(1-2):12-8. PubMed ID: 24636528 [TBL] [Abstract][Full Text] [Related]
12. B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy. Zhang L; Nomie K; Zhang H; Bell T; Pham L; Kadri S; Segal J; Li S; Zhou S; Santos D; Richard S; Sharma S; Chen W; Oriabure O; Liu Y; Huang S; Guo H; Chen Z; Tao W; Li C; Wang J; Fang B; Wang J; Li L; Badillo M; Ahmed M; Thirumurthi S; Huang SY; Shao Y; Lam L; Yi Q; Wang YL; Wang M Clin Cancer Res; 2017 Aug; 23(15):4212-4223. PubMed ID: 28348046 [No Abstract] [Full Text] [Related]
13. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities. Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700 [TBL] [Abstract][Full Text] [Related]
14. C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas. Huang W; Guo L; Liu H; Zheng B; Ying J; Lv N Int J Clin Exp Pathol; 2014; 7(9):5634-44. PubMed ID: 25337204 [TBL] [Abstract][Full Text] [Related]
15. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770 [TBL] [Abstract][Full Text] [Related]